Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ferring Pharmaceuticals
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients who are eligible for the treatment of Firmagon® (degarelix) for injection according to the approved product label, and Firmagon® (degarelix) treatment decided before study enrolment. Moreover, patient should have not previously received Firmagon® (degarelix) for injection before the study commencement date at each site. - Indication: treatment of advanced, hormone-dependent prostate cancer.
You may not be if
Patients with previous or concurrent known hypersensitivity to any component of the drug.
Clareo Health | Safety and Efficacy of Firmagon® (Degarelix) for Injection
